Going Further

For breast cancer patients, providing answers today allows for more promises tomorrow. But most diagnostic tests are unable to provide answers when it matters most–especially in women presenting low HER2 expression, an early signal of progressing cancer.

Roche Diagnostics set out to change this pattern with an advanced companion test that detects lower HER2 expression. Finally, doctors can provide a new hope for breast cancer patients, with the goal of taking them further. 

Role: Copywriter